Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York...

Por Adelson, Kerin, Ramaswamy, Bhuvaneswari, Sparano, Joseph A, Christos, Paul J, Wright, John J, Raptis, George, Han, Gang, Villalona-Calero, Miguel, Ma, Cynthia X, Hershman, Dawn, Baar, Joseph, Klein, Paula, Cigler, Tessa, Budd, G Thomas, Novik, Yelena, Tan, Antoinette R, Tannenbaum, Susan, Goel, Anupama, Levine, Ellis, Shapiro, Charles L, Andreopoulou, Eleni, Naughton, Michael, Kalinsky, Kevin, Waxman, Sam, Germain, Doris
Publicado no NPJ Breast Cancer (2016)